抗肿瘤药研 究进展与方向资料汇编.pptVIP

抗肿瘤药物研究进展;现 状;现 状;Statistic Data;Statistic Data;Statistic data;Statistic data; Statistic data Cancer Incidence Rank and Rates per 100,000 by Cancer Site and Country,GloboCan,2002;发展战略; 抗肿瘤药物研究与治疗的历程; 抗癌药物的发展趋势与方向;信号传导阻滞剂所涉及的受体家族  —生长因子受体; 信号传递靶向药物开发范例;格列卫(Gleevec);Gleevec作用机理;艾瑞萨(Iressa, Gefitinib);Tarceva(Erlotinib);Avastin(Bevacizumab);N-{3-chloro-4-[(3-fluoro-benzyl)oxy]phenyl}-6-[5-({2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine or N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonyleth